Biomedical Engineering Reference
In-Depth Information
and what did not. This market research intelligence can provide guidance on all
major new product launch planning. In addition, more rigorous statistical empirical
research on launch strategies as well as on other stages in the life cycle (growth,
mature, and decline) will be valuable.
Finally, as the role of physical sample drop declines and alternative sample distri-
bution channels expand, pharmaceutical companies need to understand the relative
effectiveness of different sample delivery channels such as sample signature, vouch-
ers, e-sampling, and patient assistance program. This new sampling mix optimiza-
tion is an important issue in the new era of multiple-channel sample distribution.
References
Adair RF, Holmgren LR (2005) Do drug samples infl uence resident prescribing behavior? Am J
Med 118(8):881-884
Armstrong GM, Kotler P (2009) Marketing, an introduction, 10th edn. Prentice Hall, Upper Saddle
River, NJ
Backer EL, Lebsackh JA, Van Tonder RJ, Crabtree BF (2000) The value of pharmaceutical repre-
sentative visits and medication samples in community-based family practice. J Fam Pract
49:811-816
Bawa K, Shoemaker R (2004) The effects of free sample promotions on incremental brand sales.
Mark Sci 23(3):345-363
Boltri JM, Gordon ER, Vogel RL (2002) Effect of antihypertensive samples on physician prescrib-
ing patterns. Fam Med, 34:729-731
Brewer D (1998) The effect of drug sampling policies on residents' prescribing. Fam Med 30:
482-486
Chew LD, O'Young TS, Hazlet TK, Bradley KA, Maynard C, Lessler DS (2000) A physician
survey of the effect of drug sample availability on physician behavior. J Gen Intern Med 15:
478-483
Chimonas S, Kassirer JP (2009) No more free drug samples? PLoS Med 6(5):e1000074.
doi:
10.1371/journal.pmed.1000074
Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmerlstein DU (2008)
Characteristics of recipients of free prescription drug samples: a nationally representative
analysis. Am J Public Health 98(2):284-289
Dong X, Xie Y (2011) The role of experimentation vs. subsidy in physician's dispensing of free
drug samples. Working paper, Santa Clara University
Donohue JM, Cevasco M, Rosenthal MB (2007) A decade of direct-to-consumer advertising of
prescription drugs. N Engl J Med 357:673-681
Gönül FF, Carter F, Petrova E, Srinivasan K (2001) Promotion of prescription drugs and its impact
on physician's choice behavior. J Mark 65(3):79-90
Henry J. Kaiser Foundation (2002) National survey of physicians, part II: doctors and prescription
drugs. Available at
http://www.kff.org/rxdrugs/loader.cfm?url=/commonspot/security/getfi le.
cfm&PageID=13965
. Accessed 1 Aug 2011
Manchanda P, Rossi PE, Chintagunta PK (2004) Response modeling with nonrandom marketing-
mix variables. J Mark Res 41:467-478
Manchanda P, Xie Y, Youn N (2008) The role of targeted communication and contagion in new
product adoption. Mark Sci 27(6):950-961
Mizik N, Jacobson R (2004) Are physicians 'easy marks'? Quantifying the effects of detailing and
sampling on new prescriptions. Manag Sci 50(12):1704-1715
Montoya R, Netzer O, Jedidi K (2010) Dynamic allocation of pharmaceutical detailing and sam-
pling for long-term profi tability. Mark Sci 29(5):909-924
Search WWH ::
Custom Search